Background. Blood conservation has become an important issue in cardia
c surgery. This study was undertaken to determine if the need of blood
transfusion could be predicted from preoperative patient variables. M
ethods. From January 1, 1992, to December 31, 1993, 2,033 patients hav
ing isolated coronary artery bypass grafting procedures were studied;
1,446 (71%) were male and 587 (29%), female. The mean age was 65.1 +/-
9.9 years (range, 31 to 88 years). Emergency operation, urgent operat
ion, and reoperations were done in 78 (4%), 188 (9%), and 189 (9%) pat
ients, respectively. In the entire group, 1,245 (61%) received transfu
sion during hospitalization, and 788 (39%) did not. Logistic regressio
n analysis was used to construct a model that predicted the need of tr
ansfusion of packed red blood cells after coronary artery bypass graft
ing. A transfusion risk score was constructed by assigning points to i
ndependent predictive factors on the basis of the logistic regression
coefficient and the odds ratio. Preoperative predictors of transfusion
were emergency operation, urgent operation, cardiogenic shock, cathet
erization-induced coronary occlusion, low body mass index, left ventri
cular ejection fraction lower than 0.30, age greater than 74 years, fe
male sex, low red cell mass, peripheral vascular disease, insulin-depe
ndent diabetes, creatinine level greater than 1.8 mg/dL, albumin value
lower than 4 g/dL, and redo operation. Results. The mean transfusion
risk score for patients receiving 0, 1 to 4, and greater than 4 units
of packed red blood cells was 2.3 +/- 0.9, 5.2 +/- 3.0, and 9.6 +/- 3.
5, respectively (p = 0.001). Patients with a score higher than 6 had a
95% transfusion incidence. The predictive model was validated on 422
patients having coronary artery bypass grafting from January 1 to May
31, 1994. The observed rates of the validation group fell within the 9
5% confidence intervals of the predicted rates. Conclusions. These dat
a demonstrate that readily available patient variables can predict pat
ients at risk for transfusion. Routine use of aprotinin and other adju
stments of cardiopulmonary bypass should be considered to reduce trans
fusion in high-risk patients.